Guide for diagnosis and treatment of hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Hepatocellular carcinoma (HCC) is ranked as the 5(th) common type of cancer worldwide and is considered as the 3(rd) common reason for cancer-related deaths. HCC often occurs on top of a cirrhotic liver. The prognosis is determined by several factors; tumour extension, alpha-fetoprotein (AFP) concentration, histologic subtype of the tumour, degree of liver dysfunction, and the patient's performance status. HCC prognosis is strongly correlated with diagnostic delay. To date, no ideal screening modality has been developed. Analysis of recent studies showed that AFP assessment lacks adequate sensitivity and specificity for effective surveillance and diagnosis. Many tumour markers have been tested in clinical trials without progressing to routine use in clinical practice. Thus, surveillance is still based on ultrasound (US) examination every 6 mo. Imaging studies for diagnosis of HCC can fall into one of two main categories: routine non-invasive studies such as US, computed tomography (CT), and magnetic resonance imaging, and more specialized invasive techniques including CT during hepatic arteriography and CT arterial portography in addition to the conventional hepatic angiography. This article provides an overview and spotlight on the different diagnostic modalities and treatment options of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, Z., Zhong, L., Teng, M., Fan, J., Tang, H., Wu, J., Chen, H., Wang, Z., Qiu, G., & Peng, Z. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.04.001 · Cited by 123
RetractedEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T., & Shimotohno, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209283 · Cited by 1,147
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
SINGAL, A., VOLK, M. L., WALJEE, A., SALGIA, R., HIGGINS, P., ROGERS, M. A. M., & MARRERO, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 819
Lin28 promotes transformation and is associated with advanced human malignancies
Viswanathan, S. R., Powers, J. T., Einhorn, W., Hoshida, Y., Ng, T. L., Toffanin, S., O'Sullivan, M., Lu, J., Phillips, L. A., Lockhart, V. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.392 · Cited by 814
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., Ambs, S., Chen, Y., Meltzer, P. S., Croce, C. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901282 · Cited by 802
Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E., & Thorgeirsson, S. S. (2009) · Oncogene · doi:10.1038/onc.2009.211 · Cited by 733
Trevisani, F., D'Intino, P. E., Morselli-Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., De Notariis, S., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 731
Identification of metastasis-related microRNAs in hepatocellular carcinoma
Budhu, A., Jia, H.-L., Forgues, M., Liu, C.-G., Goldstein, D., Lam, A., Zanetti, K. A., Ye, Q.-H., Qin, L.-X., Croce, C. M., et al. (2008) · Hepatology · doi:10.1002/hep.22160 · Cited by 697
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
Liebman, H. A., Furie, B. C., Tong, M. J., Blanchard, R. A., Lo, K.-J., Lee, S.-D., Coleman, M. S., & Furie, B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102204 · Cited by 617
Tsai, W.-C., Hsu, P. W.-C., Lai, T.-C., Chau, G.-Y., Lin, C.-W., Chen, C.-M., Lin, C.-D., Liao, Y.-L., Wang, J.-L., Chau, Y.-P., et al. (2009) · Hepatology · doi:10.1002/hep.22806 · Cited by 583
Shibata, T., Iimuro, Y., Yamamoto, Y., Maetani, Y., Ametani, F., Itoh, K., & Konishi, J. (2002) · Radiology · doi:10.1148/radiol.2232010775 · Cited by 575
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., & Duca, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00467.x · Cited by 540
Silva, M. A., Hegab, B., Hyde, C., Guo, B., Buckels, J. A. C., & Mirza, D. F. (2008) · Gut · doi:10.1136/gut.2008.149062 · Cited by 536
Jiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R., & Schmittgen, T. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0523 · Cited by 511
Burrel, M., Llovet, J. M., Ayuso, C., Iglesias, C., Sala, M., Miquel, R., Caralt, T., Ayuso, J. R., Solé, M., Sanchez, M., et al. (2003) · Hepatology · doi:10.1002/hep.1840380430 · Cited by 451
Screening for hepatocellular carcinoma
Collier, J., & Sherman, M. (1998) · Hepatology · doi:10.1002/hep.510270140 · Cited by 425
Gupta, S., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 420
Fornari, F., Gramantieri, L., Giovannini, C., Veronese, A., Ferracin, M., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Tavolari, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4797 · Cited by 401
Fornari, F., Milazzo, M., Chieco, P., Negrini, M., Calin, G. A., Grazi, G. L., Pollutri, D., Croce, C. M., Bolondi, L., & Gramantieri, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0145 · Cited by 396
Shen, Q., Fan, J., Yang, X.-R., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
Lu, D. S. K., Yu, N. C., Raman, S. S., Limanond, P., Lassman, C., Murray, K., Tong, M. J., Amado, R. G., & Busuttil, R. W. (2005) · Radiology · doi:10.1148/radiol.2343040153 · Cited by 387
Marrero, J. A., Su, G. L., Wei, W., Emick, D., Conjeevaram, H. S., Fontana, R. J., & Lok, A. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50195 · Cited by 387
Microbubble ultrasound contrast agents: an update
Quaia, E. (2007) · European Radiology · doi:10.1007/s00330-007-0623-0 · Cited by 374
Sherman, M., Peltekian, K. M., & Lee, C. (1995) · Hepatology · doi:10.1002/hep.1840220210 · Cited by 357
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.019 · Cited by 350
Diagnosis of hepatocellular carcinoma
Bialecki, E. S., & Di Bisceglie, A. M. (2005) · HPB · doi:10.1080/13651820410024049 · Cited by 334
Epidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
Heiken, J. P., Weyman, P. J., Lee, J. K., Balfe, D. M., Picus, D., Brunt, E. M., & Flye, M. W. (1989) · Radiology · doi:10.1148/radiology.171.1.2538862 · Cited by 315
MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
Gramantieri, L., Fornari, F., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Bolondi, L., & Negrini, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0092 · Cited by 308
MicroRNA involvement in hepatocellular carcinoma
Gramantieri, L., Fornari, F., Callegari, E., Sabbioni, S., Lanza, G., Croce, C. M., Bolondi, L., & Negrini, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00533.x · Cited by 304
Brunello, F., Veltri, A., Carucci, P., Pagano, E., Ciccone, G., Moretto, P., Sacchetto, P., Gandini, G., & Rizzetto, M. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701885481 · Cited by 302
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., & Beaugrand, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80468-4 · Cited by 296
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
Li, W., Xie, L., He, X., Li, J., Tu, K., Wei, L., Wu, J., Guo, Y., Ma, X., Zhang, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23693 · Cited by 293
Major achievements in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60381-0 · Cited by 283
Yu, N. C., Chaudhari, V., Raman, S. S., Lassman, C., Tong, M. J., Busuttil, R. W., & Lu, D. S. K. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.017 · Cited by 265
Obi, S., Yoshida, H., Toune, R., Unuma, T., Kanda, M., Sato, S., Tateishi, R., Teratani, T., Shiina, S., & Omata, M. (2006) · Cancer · doi:10.1002/cncr.21832 · Cited by 262
Orlando, A., Leandro, G., Olivo, M., Andriulli, A., & Cottone, M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.80 · Cited by 257
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
Borel, F., Konstantinova, P., & Jansen, P. L. M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.026 · Cited by 245
Westwood, M., Joore, M., Grutters, J., Redekop, K., Armstrong, N., Lee, K., Gloy, V, Raatz, H., Misso, K., Severens, J., et al. (2013) · Health Technol Assess · doi:10.3310/hta17160 · Cited by 226
Ebara, M., Okabe, S., Kita, K., Sugiura, N., Fukuda, H., Yoshikawa, M., Kondo, F., & Saisho, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.033 · Cited by 208
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen, D., Sung, J., Sheu, J., Lai, M., How, S.-W., Hsu, H., Lee, C., & Wei, T. (1984) · PubMed · Cited by 202
Park, M. J., Kim, Y. K., Lee, M. W., Lee, W. J., Kim, Y.-S., Kim, S. H., Choi, D., & Rhim, H. (2012) · Radiology · doi:10.1148/radiol.12112517 · Cited by 190
Seong, J., Park, H. C., Han, K., & Chon, C. Y. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03929-9 · Cited by 167
Nakamura, S., Nouso, K., Sakaguchi, K., Ito, Y. M., Ohashi, Y., Kobayashi, Y., Toshikuni, N., Tanaka, H., Miyake, Y., Matsumoto, E., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00681.x · Cited by 166
Pathogenesis of hepatocellular carcinoma
Moradpour, D., & Blum, H. E. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200505000-00002 · Cited by 164
Khan, K. N., Yatsuhashi, H., Yamasaki, K., Yamasaki, M., Inoue, O., Koga, M., & Yano, M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80072-0 · Cited by 162
Nguyen, M. H., Garcia, R. T., Simpson, P. W., Wright, T. L., & Keeffe, E. B. (2002) · Hepatology · doi:10.1053/jhep.2002.34744 · Cited by 159
Dodd, G. D., Miller, W. J. W., BARON, R. L., Skolnick, M. L., & Campbell, W. L. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.159.4.1326883 · Cited by 152
Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical review
Weitz, I. C., & Liebman, H. A. (1993) · Hepatology · doi:10.1002/hep.1840180434 · Cited by 152
Oka, H., Saito, A., Ito, K., Kumada, T., Satomura, S., Kasugai, H., Osaki, Y., Seki, T., Kudo, M., & Tanaka, M. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02643.x · Cited by 143
Role of hepatitis C infection in chronic liver disease in Egypt.
Strickland, G. T., Elhefni, H., Salman, T., Waked, I. A., Abdel-Hamid, M., Mikhail, N. N. H., Esmat, G., & Fix, A. D. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.67.436 · Cited by 130
Granito, A., Galassi, M., Piscaglia, F., Romanini, L., Lucidi, V., Renzulli, M., Borghi, A., Grazioli, L., Golfieri, R., & Bolondi, L. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12166 · Cited by 129
Radiofrequency Ablation of Liver Cancer
Lencioni, R. A., & Crocetti, L. (2007) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2007.08.006 · Cited by 128
Han, Z., Chen, H., Fan, J., Wu, J., Tang, H., & Peng, Z. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1076-z · Cited by 123
Sterling, R. K., Wright, E. C., Morgan, T. R. M., Seeff, L. B., Hoefs, J. C., Bisceglie, A. M. D., Dienstag, J. L., & Lok, A. S.-F. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.312 · Cited by 122
Rong, M., Chen, G., & Dang, Y. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-21 · Cited by 120
El‐Zayadi, A. (2001) · Hepatology Research · doi:10.1016/s1386-6346(00)00105-4 · Cited by 118
Khien, V. V., Mao, H. V., Chinh, T.-T., Ha, P. T., Bang, M. H., Lac, B. V., Hop, T. V., Tuan, N. A., Don, L. V., Taketa, K., et al. (2001) · The International Journal of Biological Markers · doi:10.1177/172460080101600204 · Cited by 113
Diagnosis, staging and treatment of hepatocellular carcinoma
França, A. V. C., Elías, J., Lima, B. L. G., Martinelli, A. L. C., & Carrilho, F. J. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004001100015 · Cited by 110
Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma
Hwang, S. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i17.2472 · Cited by 109
Larcos, G., Sorokopud, H., Berry, G. R., & Farrell, G. C. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.2.9694470 · Cited by 106
Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening
Li, L., Guo, Z., Wang, J., Mao, Y., & Gao, Q. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2317-y · Cited by 105
Changing pattern of hepatitis C virus spread in rural areas of Egypt
Arafa, N., El‐Hoseiny, M., Rekacewicz, C., Bakr, I., El-Kafrawy, S. A., El-Daly, M. M., Aoun, S., Marzouk, D., Mohamed, M. K., & Fontanet, A. L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.021 · Cited by 103
Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma
Szklaruk, J., Silverman, P. M., & Charnsangavej, C. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.180.2.1800441 · Cited by 87
Embolization of liver tumors: Past, present and future
Rammohan, A., Sathyanesan, J., Ramaswami, S., Lakshmanan, A., Senthil-Kumar, P., Srinivasan, U. P., Ramasamy, R., & Ravichandran, P. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i9.405 · Cited by 87
Thrombocytosis and Hepatocellular Carcinoma
Carr, B. I., & Guerra, V. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2527-3 · Cited by 83
Structures of disease-specific serum alpha-fetoprotein isoforms
Johnson, P. J., Poon, T. C. W., Hjelm, N. M., Ho, C. S., Blake, C., & Ho, S. K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1441 · Cited by 81
Kuang, M., Lu, M., Xie, X.-Y., Xu, H.-X., Xu, Z., Liu, G.-J., Yin, X.-Y., Huang, J.-F., & Lencioni, R. A. (2009) · Radiology · doi:10.1148/radiol.2532082021 · Cited by 80
Murakami, Y., Tamori, A., Itami, S., Tanahashi, T., Toyoda, H., Tanaka, M., Wu, W., Brojigin, N., Kaneoka, Y., Maeda, A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-99 · Cited by 77
Wang, C., Song, B., Song, W., Liu, J., Sun, A.-M., Wu, D., Yu, H., Lian, J., Chen, L., & Han, J. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06758.x · Cited by 73
Fu, X., Wang, Q., Chen, J., Huang, X., Chen, X., Cao, L., Tan, H., Li, W., Zhang, L., Bi, J., et al. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9969-5 · Cited by 70
Eastman, R. C., Carson, R. E., Orloff, D. G., Cochran, C. S., Perdue, J. F., Rechler, M. M., Lanau, F., Roberts, C. T., Shapiro, J., & Roth, J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115803 · Cited by 68
miR-17-5p as a Novel Prognostic Marker for Hepatocellular Carcinoma
Chen, L., Jiang, M., Yuan, W., & Tang, H. (2012) · Journal of Investigative Surgery · doi:10.3109/08941939.2011.618523 · Cited by 68
Screening for hepatocellular carcinoma
Parvez, T., Parvez, B., Pervaiz, K., Gumgumji, A. A., Ahmadi, S. A., Sabir, A. A., & Khawaja, F. I. (2000) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.67.s1.30 · Cited by 67
Sakisaka, S., Watanabe, M., Tateishi, H., Harada, M., Shakado, S., Mimura, Y., Gondo, K., YOSHITAKE, M., Noguchi, K., Hino, T., et al. (1993) · Hepatology · doi:10.1002/hep.1840180612 · Cited by 59
Na, K., Jeong, S., Lee, M. J., Cho, S. Y., Kim, S. A., Lee, M., Song, S. Y., Kim, H., Kim, K. S., Lee, H. W., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28020 · Cited by 55
Image-guided thermal ablation of hepatocellular carcinoma
Lencioni, R. A., & Crocetti, L. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.003 · Cited by 49
Tsai, J.-F., Jeng, J., Chuang, L.-Y., Yang, M., Ho, M., Chang, W., Hsieh, M., Lin, Z., & Tsai, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.250 · Cited by 48
Needle Tract Implantation of Hepatocellular Carcinoma After Fine Needle Biopsy
Liu, Y., Chen, C., Chen, Y., Wang, C., Wang, S.-H., & Lin, C. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9354-3 · Cited by 46
Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis
Henry, L., Lavabre‐Bertrand, T., Vercambre, L., Ramos, J., Carillo, S., Guiraud, I., Pouderoux, P., Bismuth, M., Valats, J.-C., Dematteï, C., et al. (2009) · Gut · doi:10.1136/gut.2008.157016 · Cited by 42
Lencioni, R. A., Crocetti, L., SIMONE, P. D., & Filipponi, F. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01109.x · Cited by 35
Hepatoma With Severe Non-Islet Cell Tumor Hypoglycemia
Tietge, U. J. F., Schöfl, C., OCRAN, K. W., Wagner, S., Böker, K. H. W., Brabant, G. E., Zapf, J., & Manns, M. P. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00297.x · Cited by 32
Advances in Echo Imaging Using Contrast Enhancement
(1993) · Springer eBooks · doi:10.1007/978-94-015-8126-4 · Cited by 18
Helzberg, J. H., McPhee, M. S., Zarling, E. J., & Lukert, B. P. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80152-9 · Cited by 16
Ohki, T., Tateishi, R., Akahane, M., Mikami, S., Sato, M., Uchino, K., Arano, T., Enooku, K., Kondo, Y., Yamashiki, N., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.109 · Cited by 12
HCC Screening and Surveillance
Masuzaki, R., & Omata, M. (2009) · CRC Press eBooks · doi:10.3109/9780203092880-4 · Cited by 2
Cited by
Yeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., et al. (2023) · doi:10.1101/2023.02.06.23285449 · Cited by 666
Yeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., et al. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0089 · Cited by 662
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Desai, A., Sandhu, S., Lai, J.-P., & Sandhu, D. S. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i1.1 · Cited by 317
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma
Mak, L.-Y., Cruz-Ramón, V., Chinchilla-López, P., Torres, H. A., LoConte, N. K., Rice, J. P., Foxhall, L. E., Sturgis, E. M., Merrill, J. K., Bailey, H. H., et al. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200939 · Cited by 237
Metadata
- Authors
- Attwa, M. H.
- Venue
- World Journal of Hepatology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 7
- Issue
- 12
- Pages
- 1632
- ISSN
- 1948-5182 (ISSN-L)
- OpenAlex
- W749205244
- Cited by
- 242
- References
- 100
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.